Insmed | INSM - Interest Income

Stock Price
135.17
Daily Change
-8.66 -6.02%
Monthly
-8.86%
Yearly
93.96%
Q2 Forecast
132.28

Insmed reported $765K in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Cytokinetics USD 10.25M 2.75M Sep/2025
DBV Technologies USD -0.32 0.02 Sep/2024
Gilead Sciences USD 95M 7M Dec/2025
Heron Therapeutics USD 433K 277K Dec/2021
Insmed USD 765K 55K Sep/2024
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025